MicroDose Therapeutx, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1998-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://mdtx.com
Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- MicroDose Therapeutx, Inc
- Target Recruit Count
- 10
- Registration Number
- NCT01556607
- Locations
- 🇺🇸
West Coast Clinical Trials, Costa Mesa, California, United States
A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers
- First Posted Date
- 2011-12-09
- Last Posted Date
- 2012-04-12
- Lead Sponsor
- MicroDose Therapeutx, Inc
- Target Recruit Count
- 36
- Registration Number
- NCT01489306
- Locations
- 🇺🇸
West Coast Clinical Trials, Cypress, California, United States
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Drug SafetyRespiratory Syncytial Virus Infections
- Interventions
- First Posted Date
- 2011-05-17
- Last Posted Date
- 2012-04-12
- Lead Sponsor
- MicroDose Therapeutx, Inc
- Target Recruit Count
- 48
- Registration Number
- NCT01355016
- Locations
- 🇺🇸
West Coast Clinical Trials, Cypress, California, United States
News
No news found